A case-control study in the Republic of Korea evaluated the protective effectiveness of the hantavirus vaccine. Point estimates showed increasing effectiveness with increasing numbers of doses received: 25% for one dose, 46% for two doses, and 75% for three doses. All 95% confidence intervals overlapped zero; therefore, the findings could be due to chance.
|Number of pages||3|
|Journal||Emerging infectious diseases|
|Publication status||Published - 2004 Dec|
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
- Infectious Diseases